Bone morphogenetic protein 4 inhibits insulin secretion from rodent beta cells through regulation of calbindin1 expression and reduced voltage-dependent calcium currents.

about

Serotonin (5-HT) receptor 2b activation augments glucose-stimulated insulin secretion in human and mouse islets of Langerhans.Dual Effect of Rosuvastatin on Glucose Homeostasis Through Improved Insulin Sensitivity and Reduced Insulin Secretion.

P2860

Q35886138-A6427B31-7E58-43FB-A41F-A3C234066E17 Q36084295-28B00C25-E8DF-4994-81A2-0F3A6B297F9D

P2860

Bone morphogenetic protein 4 inhibits insulin secretion from rodent beta cells through regulation of calbindin1 expression and reduced voltage-dependent calcium currents.

Item

http://www.wikidata.org/entity/Q38300086

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Bone morphogenetic protein 4 i ...... ge-dependent calcium currents.

@en

type

Item

label

Bone morphogenetic protein 4 i ...... ge-dependent calcium currents.

@en

prefLabel

Bone morphogenetic protein 4 i ...... ge-dependent calcium currents.

@en

P1476

Bone morphogenetic protein 4 i ...... age-dependent calcium currents

@en

P2093

Christine Bruun

http://www.w3.org/2001/XMLSchema#string

Gitte L Christensen

http://www.w3.org/2001/XMLSchema#string

Josefine Friberg

http://www.w3.org/2001/XMLSchema#string

Klaus S Frederiksen

http://www.w3.org/2001/XMLSchema#string

Maria L B Jacobsen

http://www.w3.org/2001/XMLSchema#string

Michael Meyer

http://www.w3.org/2001/XMLSchema#string

P2860

Conditional expression of Smad7 in pancreatic beta cells disrupts TGF-beta signaling and induces reversible diabetes mellitus

Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes

Activation of bone morphogenetic protein 4 signaling leads to glomerulosclerosis that mimics diabetic nephropathy

Inhibition of Id1 augments insulin secretion and protects against high-fat diet-induced glucose intolerance.

Five stages of evolving beta-cell dysfunction during progression to diabetes.

Ataxia and altered dendritic calcium signaling in mice carrying a targeted null mutation of the calbindin D28k gene.

SUR1 regulates PKA-independent cAMP-induced granule priming in mouse pancreatic B-cells

A gene expression network model of type 2 diabetes links cell cycle regulation in islets with diabetes susceptibility.

Extracellular modulation of BMP activity in patterning the dorsoventral axis.

The bone morphogenic protein inhibitor, noggin, reduces glycemia and vascular inflammation in db/db mice.

P2888

s00125-015-3568-x

P304

1282-1290

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00125-015-3568-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-04-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1052155174

http://www.w3.org/2001/XMLSchema#string

P698

25828920

http://www.w3.org/2001/XMLSchema#string

P921

morphogenesis

Bone morphogenetic protein 4 inhibits insulin secretion from rodent beta cells through regulation of calbindin1 expression and reduced voltage-dependent calcium currents.

about

P2860

P2860

Bone morphogenetic protein 4 inhibits insulin secretion from rodent beta cells through regulation of calbindin1 expression and reduced voltage-dependent calcium currents.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921